Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia.

International journal of laboratory hematology - 1 Aug 2012

Zhong Y, Feng J, Chen B, Cheng L, Li Y, Qian J, Ding J, Gao F, Xia G

Abstract excerpt

INTRODUCTION: In the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway, STAT3 is one of the most prominent prognosis factors for cancer and leukemia. STAT3 activation might promote cellular transformation and therefore have an important role in human tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged, 80 and over
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Asian People

Share to Drug Resistance, Neoplasm

Share to Leukemia, Myeloid, Acute

Share to STAT3 Transcription Factor

Share to Treatment Outcome

Source

Identifiers

PMID: 22376160
DOI: 10.1111/j.1751-553X.2012.01406.x

Genes

STAT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22376160-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia.PMID 22376160Read ↗

STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemiaSemantic proximity Read ↗

Investigation and analysis of single nucleotide polymorphisms in Janus kinase/signal transducer and activator of transcription genes with leukemia.Semantic proximity Read ↗

STAT5 gene polymorphisms are associated with the response of acute myeloid leukemia patients to Ara-C-based chemotherapy.Semantic proximity Read ↗

Comprehensive analysis of expression and prognosis for signal transducer and activator of transcription family in acute myeloid leukemiaSemantic proximity Read ↗

Comprehensive Analysis of the Expression and Prognosis for Signal Transducer and Activator of Transcription Family of Genes in Acute Myeloid LeukemiaSemantic proximity Read ↗

The associations of Janus kinase-2 (JAK2) A830G polymorphism and the treatment outcomes in patients with acute myeloid leukemia.Semantic proximity Read ↗

Integrated Clinical Genotype-Phenotype Characteristics of STAT3-Mutated Myeloid Neoplasms.Semantic proximity Read ↗

Dissecting Out a Rare Mutation, STAT: Features of STAT3-Mutant Myeloid Neoplasms.Semantic proximity Read ↗

SASH3 is an unfavorable prognostic immune biomarker in patients with acute myeloid leukemia(AML).Semantic proximity Read ↗

Association of Janus kinase 2 (JAK2) polymorphisms with acute leukemia susceptibility.Semantic proximity Read ↗

Roles of STAT3 in leukemia (Review)Semantic proximity Read ↗

MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.